Conjugates useful in the treatment of benign prostatic hyperplasia
US6177404A · kind A · utility
76Cited by
6References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 3, 1998 |
| Grant date | Jan 23, 2001 |
| Priority date | — |
| Expiry date | Aug 3, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/65
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Novel pharmaceutical compositions useful for the treatment of benign prostatic hyperplasia which comprises novel oligopeptides, which are selectively cleaved by enzymatically active PSA, in conjugation with a cytotoxic agent are described. Methods of treating benign prostate hypertrophy are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.